Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


13.05.2024

1 BMC Pediatr
8 BMJ
1 Epidemiol Infect
1 J Clin Microbiol
1 J Epidemiol Community Health
1 J Gen Virol
2 J Immunol
1 J Infect Dis
5 JAMA
2 Lancet
1 Pediatrics
1 PLoS Comput Biol
36 PLoS One
1 Proc Natl Acad Sci U S A
7 Vaccine
1 Virus Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Pediatr

  1. LIN X, Chen X, Chen Y, Xu P, et al
    Sleep initiation patterns and sleep quality among toddlers in the southeast of China: initial study results.
    BMC Pediatr. 2024;24:298.
    PubMed         Abstract available


    BMJ


  2. Seven days in medicine: 1-7 May 2024.
    BMJ. 2024;385:q1022.
    PubMed        

  3. MAHASE E
    Workforce and winter under Labour: Wes Streeting on his plan for the NHS and ending the strikes.
    BMJ. 2024;385:q992.
    PubMed        

  4. WONG G, Kelly M
    NHS funding for a secure future: naming the elephant in the room.
    BMJ. 2024;385:q1036.
    PubMed        

  5. NAKWEYA G
    Moderna's decision to shelve vaccine plant in Kenya should encourage global south's self-reliance, says global health adviser.
    BMJ. 2024;385:q1051.
    PubMed        

  6. MAFI A
    Doctors in training should be at the top of the workforce priority list.
    BMJ. 2024;385:q1045.
    PubMed        

  7. WATERS A
    LMC removes GP from committee amid row over attendance at meetings.
    BMJ. 2024;385:q1021.
    PubMed        

  8. LOOI MK
    Why WHO changed the definition of "airborne transmission" in the wake of the pandemic.
    BMJ. 2024;385:q985.
    PubMed        

  9. LYNN E
    April top picks: Hope springs eternal.
    BMJ. 2024;385:q1037.
    PubMed        


    Epidemiol Infect

  10. GUERRERO-SOLER M, Gras-Valenti P, Gomez-Sotero IL, Platas-Abenza G, et al
    Impact of COVID-19 on the degree of compliance with hand hygiene: a repeated cross-sectional study.
    Epidemiol Infect. 2024;152:e69.
    PubMed         Abstract available


    J Clin Microbiol

  11. SMY L, Ledeboer NA, Wood MG
    At-home testing for respiratory viruses: a minireview of the current landscape.
    J Clin Microbiol. 2024;62:e0031223.
    PubMed         Abstract available


    J Epidemiol Community Health

  12. YEUNG A, Wilkinson M, Bishop J, Taylor B, et al
    SARS-CoV-2 vaccine uptake and risks of severe COVID-19 disease among people prescribed opioid agonist therapy in Scotland.
    J Epidemiol Community Health. 2024;78:380-387.
    PubMed         Abstract available


    J Gen Virol

  13. KARA Y, Kizil MC, Iseri Nepesov M, Kacmaz E, et al
    Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic.
    J Gen Virol. 2024;105.
    PubMed         Abstract available


    J Immunol

  14. BOUCHER J, Gilbert C, Bose S, Tessier PA, et al
    S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
    J Immunol. 2024;212:1523-1529.
    PubMed         Abstract available

  15. SAITO S, Bozorgmehr N, Sligl W, Osman M, et al
    The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
    J Immunol. 2024;212:1540-1552.
    PubMed         Abstract available


    J Infect Dis

  16. HOY G, Stadlbauer D, Balmaseda A, Kuan G, et al
    Humoral correlates of protection against influenza A H3N2 virus infection.
    J Infect Dis. 2024 May 9:jiae258. doi: 10.1093.
    PubMed         Abstract available


    JAMA

  17. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed        

  18. HARRIS E
    Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
    JAMA. 2024;331:1439-1440.
    PubMed        

  19. HARRIS E
    Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
    PubMed        

  20. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    PubMed        

  21. ANDERER S
    Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    PubMed        


    Lancet

  22. KIVIMAKI M, Batty GD
    Work as a health risk.
    Lancet. 2024;403:1747-1748.
    PubMed        

  23. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
    Anticipating a MERS-like coronavirus as a potential pandemic threat.
    Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
    PubMed        


    Pediatrics

  24. MORO PL, Scheffey A, Gallego R, Jones JM, et al
    Incorrect Administration of Adult RSV Vaccines to Young Children.
    Pediatrics. 2024;153:e2024066174.
    PubMed        


    PLoS Comput Biol

  25. BOUMAN JA, Hauser A, Grimm SL, Wohlfender M, et al
    Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models.
    PLoS Comput Biol. 2024;20:e1011575.
    PubMed         Abstract available


    PLoS One

  26. SELVAVINAYAGAM TS, Viswanathan V, Ramalingam A, Kangusamy B, et al
    Prevalence of Noncommunicable Disease (NCDs) risk factors in Tamil Nadu: Tamil Nadu STEPS Survey (TN STEPS), 2020.
    PLoS One. 2024;19:e0298340.
    PubMed         Abstract available

  27. VOLTMER K, von Salisch M
    Longitudinal prediction of primary school children's COVID-related future anxiety in the second year of the pandemic in Germany.
    PLoS One. 2024;19:e0302065.
    PubMed         Abstract available

  28. IQBAL NT, Ahmed K, Sattar T, Aziz F, et al
    BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
    PLoS One. 2024;19:e0302722.
    PubMed         Abstract available

  29. VAMEGHI M, Saatchi M, Bahrami G, Soleimani F, et al
    How did we protect children against COVID-19 in Iran? Prevalence of COVID-19 and vaccination in the socio-economic context of COVID-19 epidemic.
    PLoS One. 2024;19:e0303043.
    PubMed         Abstract available

  30. MALKOWSKI OS, Townsend NP, Kelson MJ, Foster CEM, et al
    Socio-economic inequalities in the breadth of internet use before and during the COVID-19 pandemic among older adults in England.
    PLoS One. 2024;19:e0303061.
    PubMed         Abstract available

  31. AL MAQBALI M, Alsayed A, Hughes C, Hacker E, et al
    Stress, anxiety, depression and sleep disturbance among healthcare professional during the COVID-19 pandemic: An umbrella review of 72 meta-analyses.
    PLoS One. 2024;19:e0302597.
    PubMed         Abstract available

  32. OMALE UI, Ikegwuonu CO, Nkwo GE, Nwali UIA, et al
    COVID-19 and COVID-19 vaccination experiences and perceptions among health workers during the pandemic in Ebonyi state, Nigeria: An analytical cross-sectional study.
    PLoS One. 2024;19:e0303172.
    PubMed         Abstract available

  33. AGGARWAL S, Singh L, Alam U, Sharma S, et al
    COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model.
    PLoS One. 2024;19:e0294480.
    PubMed         Abstract available

  34. LIU X, Xie CP
    Person-organization fit and job burnout of researchers during the COVID-19 pandemic: Heterogeneity in eleven countries.
    PLoS One. 2024;19:e0302296.
    PubMed         Abstract available

  35. NAPOLITANO JM, Srikanth S, Noorai RE, Wilson S, et al
    SARS-CoV-2 variant introduction following spring break travel and transmission mitigation strategies.
    PLoS One. 2024;19:e0301225.
    PubMed         Abstract available

  36. MEYER C, Crayton E, Wright A, Spyer M, et al
    Factors influencing uptake of protective behaviours by healthcare workers in England during the COVID-19 pandemic: A theory-based mixed-methods study.
    PLoS One. 2024;19:e0299823.
    PubMed         Abstract available

  37. GALIERO R, Loffredo G, Simeon V, Caturano A, et al
    Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy.
    PLoS One. 2024;19:e0296495.
    PubMed         Abstract available

  38. PASAT Z, Sinn CJ, Rahman B, Gayowsky A, et al
    The relationship between patient experience and real-world digital health access in primary care: A population-based cross-sectional study.
    PLoS One. 2024;19:e0299005.
    PubMed         Abstract available

  39. SCOGLIO AAJ, Nishimi K, Choi KW, Koenen KC, et al
    Prior resilience to trauma & coping during the COVID-19 pandemic.
    PLoS One. 2024;19:e0297169.
    PubMed         Abstract available

  40. GROSS RS, Thaweethai T, Rosenzweig EB, Chan J, et al
    Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.
    PLoS One. 2024;19:e0285635.
    PubMed         Abstract available

  41. ROCA C, Asturizaga A, Villca N, Cabrera R, et al
    Relationship between sociodemographic, clinical, and laboratory characteristics and severity of COVID-19 in pediatric patients.
    PLoS One. 2024;19:e0283037.
    PubMed         Abstract available

  42. FERNANDEZ D, Perez-Alvarez N, Molist G
    COVID-19 patient profiles over four waves in Barcelona metropolitan area: A clustering approach.
    PLoS One. 2024;19:e0302461.
    PubMed         Abstract available

  43. DE WITTE D, Abad AA, Neyens T, Verbeke G, et al
    A joint penalized spline smoothing model for the number of positive and negative COVID-19 tests.
    PLoS One. 2024;19:e0303254.
    PubMed         Abstract available

  44. AALOKKEN TM, Ashraf H, Einvik G, Lerum TV, et al
    CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: A prospective cohort study.
    PLoS One. 2024;19:e0302896.
    PubMed         Abstract available

  45. GNADE CM, Avery CC, Yang Z, Pickett CM, et al
    Social media trends in obstetrics and gynecology residency programs on Instagram and X (Twitter).
    PLoS One. 2024;19:e0296930.
    PubMed         Abstract available

  46. CARDENAS-CALLE M, Patino L, Pernia B, Erazo R, et al
    Detection of thermotolerant coliforms and SARS-CoV-2 RNA in sewage and recreational waters in the Ecuadorian coast: A call for improving water quality regulation.
    PLoS One. 2024;19:e0302000.
    PubMed         Abstract available

  47. KIM S, Lilani A, Redemptus C, Campana K, et al
    A pre-post evaluation study of a social media-based COVID-19 communication campaign to improve attitudes and behaviors toward COVID-19 vaccination in Tanzania.
    PLoS One. 2024;19:e0300206.
    PubMed         Abstract available

  48. WEBB EJD, Conaghan PG, Henderson M, Hulme C, et al
    Long-term health conditions and UK labour market outcomes during the COVID-19 pandemic.
    PLoS One. 2024;19:e0302746.
    PubMed         Abstract available

  49. DU W, Zhao L, Wu R, Huang B, et al
    Predicting drug-Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2.
    PLoS One. 2024;19:e0299696.
    PubMed         Abstract available

  50. ELIAS TP, Gebreamlak TW, Gebremeskel TT, Adde BL, et al
    Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study.
    PLoS One. 2024;19:e0298409.
    PubMed         Abstract available

  51. PALL T, Abroi A, Avi R, Niglas H, et al
    SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic.
    PLoS One. 2024;19:e0303176.
    PubMed         Abstract available

  52. RAMOS A, Martins S, Marinho AS, Norton P, et al
    Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers.
    PLoS One. 2024;19:e0303244.
    PubMed         Abstract available

  53. TO T, Zhu J, Terebessy E, Borkhoff CM, et al
    Mode of delivery and birth outcomes before and during COVID-19 -A population-based study in Ontario, Canada.
    PLoS One. 2024;19:e0303175.
    PubMed         Abstract available

  54. VINDEIRINHO JM, Oliveira R, Pinho E, Guiomar R, et al
    The potential of tailed amplicons for SARS-CoV-2 detection in Nucleic Acid Lateral Flow Assays.
    PLoS One. 2024;19:e0301234.
    PubMed         Abstract available

  55. MARTELL M, Terry N, Sengupta R, Salazar C, et al
    Open-source data pipeline for street-view images: A case study on community mobility during COVID-19 pandemic.
    PLoS One. 2024;19:e0303180.
    PubMed         Abstract available

  56. BAUTISTA-ARREDONDO LF, Munoz-Rocha TV, Figueroa JL, Tellez-Rojo MM, et al
    A surge in food insecurity during the COVID-19 pandemic in a cohort in Mexico City.
    PLoS One. 2024;19:e0297694.
    PubMed         Abstract available

  57. YASOPA O, Homkham N, Chompook P
    Factors affecting the number of influenza patients before and during COVID-19 pandemic, Thailand.
    PLoS One. 2024;19:e0303382.
    PubMed         Abstract available

  58. FERDOUS MZ, Islam MS, Kundu LR, Islam US, et al
    Patterns of eating behaviors, physical activity, and lifestyle modifications among Bangladeshi adolescents during the COVID-19 pandemic.
    PLoS One. 2024;19:e0302571.
    PubMed         Abstract available

  59. CHEN N, Wang R, Zhu W, Hao X, et al
    Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases.
    PLoS One. 2024;19:e0302865.
    PubMed         Abstract available

  60. KERN M, Glatz T, Mall MA, Seybold J, et al
    Health-related quality of life and impact of socioeconomic status among primary and secondary school students after the third COVID-19 wave in Berlin, Germany.
    PLoS One. 2024;19:e0302995.
    PubMed         Abstract available

  61. NOUR D, Ismail MB, Osman M, Rafei R, et al
    Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.
    PLoS One. 2024;19:e0302579.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  62. MORALES M, Yang MY, Goddard WA 3rd, Gray HB, et al
    Copper(II) coordination to the intrinsically disordered region of SARS-CoV-2 Nsp1.
    Proc Natl Acad Sci U S A. 2024;121:e2402653121.
    PubMed         Abstract available


    Vaccine

  63. WALLACE M, Rosenblum HG, Moulia DL, Broder KR, et al
    A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
    Vaccine. 2023 Jul 30:S0264-410X(23)00868-X. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  64. EHRLICH KB, Lyle SM, Corallo KL, Lavner JA, et al
    Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults.
    Vaccine. 2024 May 2:S0264-410X(24)00505-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  65. BENEDICT KPOZEHOUEN E, Macintyre CR, Tan TC
    Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
    Vaccine. 2024 May 3:S0264-410X(24)00445-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  66. MAUREL M, Mazagatos C, Goerlitz L, Oroszi B, et al
    Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
    Vaccine. 2024 May 3:S0264-410X(24)00497-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  67. SHI XC, Gruber JF, Ondari M, Lloyd PC, et al
    Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and older.
    Vaccine. 2024 May 3:S0264-410X(24)00478-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  68. KIM J, Chang J
    Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2.
    Vaccine. 2024 May 6:S0264-410X(24)00481-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  69. KIM DH, Lee SH, Kim J, Lee J, et al
    Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks.
    Vaccine. 2024 May 8:S0264-410X(24)00527-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virus Res

  70. WU CC, Tam EH, Shih YY, Lin YR, et al
    Exploration of influenza A virus PA protein-associated cellular proteins discloses its impact on mitochondrial function.
    Virus Res. 2024 May 6:199387. doi: 10.1016/j.virusres.2024.199387.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.